Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Mar 2026: GE HealthCare completed its US$2.3bn cash acquisition of Intelerad, which now sits within GE HealthCare's Imaging business; the deal was announced in Nov 2025. Buyers should note the change of ownership.
Data breaches, cyber incidents, regulator action and assurance status.
Sep 2026: Intelerad issued a software correction for certain InteleradPACS versions after finding a vulnerability in the InteleBrowser admin portal that could let an authenticated user gain administrator access. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Sep 2026: A PACS software correction (recall) was notified in New Zealand covering a security flaw and a rare image-deletion issue in a non-default cloud archive setup; the manufacturer found no evidence that setup is used in production.
Contract delivery, go-lives, terminations and disputes.
Jan 2025: Intelerad was awarded the West of England Imaging Network framework (PACS, RIS, image sharing and storage) for seven NHS trusts, valued at £49.85m excluding VAT.